HCW Biologics Inc.
13F holders, Q2 2024 (June 30)19holders −1
1new positions
2sold out
1famous investor
$0.65avg. 13F price*
At the end of Q2 2024, 19 institutions reported holding HCW Biologics Inc. in their 13F filings, down 1 from Q1 2024. 1 opened new positions and 2 sold out. The largest holders were Avantax Planning Partners, Inc. ($181K), HighTower Advisors, LLC ($117K) and Geode Capital Management, LLC ($110K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- HCW Biologics Inc.
- CUSIP
- 40423R105
- Latest filing quarter
- Q1 2025
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $9K |
| Exits | 2 | $262 |
All 13F filers, Q1 2024 → Q2 2024: 126,675 shares bought and 14,285 shares sold, net +112,390 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 19 holders
| Avantax Planning Partners, Inc. | 0.01% | Add +55.5% | 279,541 | $181K |
| HighTower Advisors, LLC | 0.00% | Add +0.6% | 180,810 | $117K |
| Geode Capital Management, LLC | 0.00% | Reduce -2.2% | 170,385 | $110K |
| Cresset Asset Management, LLC | 0.00% | No change | 131,990 | $85K |
| Pullen Investment Management, LLC | 0.05% | No change | 85,116 | $55K |
| Bridgeway Capital Management, LLC | 0.00% | No change | 84,700 | $55K |
| HRT Financial LP | 0.00% | Reduce -8.8% | 66,659 | $43K |
| BlackRock Inc. | 0.00% | Reduce -7.3% | 42,662 | $28K |
| Vanguard Group Inc. | 0.00% | Add +0.1% | 37,677 | $24K |
| AE Wealth Management LLC | 0.00% | No change | 30,000 | $19K |
| Jane Street Group, LLC | 0.00% | Add +40.0% | 24,137 | $16K |
| Two Sigma Investments, LP | 0.00% | Reduce -0.7% | 22,480 | $15K |
| State Street Corp. | 0.00% | No change | 21,446 | $14K |
| Citadel Advisors | 0.00% | New | 13,876 | $9K |
| Northern Trust Corp. | 0.00% | No change | 10,205 | $7K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +25.8% | 6,212 | $4K |
| UBS Group AG | 0.00% | Add +608.3% | 4,285 | $3K |
| Bank of America Corp. | 0.00% | Reduce -61.6% | 156 | $101 |
| Royal Bank of Canada | 0.00% | Add +66.8% | 407 | $0 |
"% of holder's portfolio" is HCW BIOLOGICS INC's weight in each manager's 13F, not the share of HCW Biologics Inc. the manager owns.